Seeing Is Believing
Currently out of the existing stock ratings of Michael Nedelcovych, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).
Analyst Michael Nedelcovych, currently employed at TD COWEN, carries an average stock price target met ratio of 68.06% that have a potential upside of 14.58% achieved within 189 days.
Michael Nedelcovych’s has documented 26 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JNJ, Johnson & Johnson at 13-Jul-2026.
Analyst best performing recommendations are on TAK (TAKEDA PHARMACEUTICAL CO LTD ADR).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 12/12/2022. The price target of $72.5 was fulfilled within 109 days with a profit of $13.75 (23.4%) receiving and performance score of 2.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-May-2025
$40
$0.95 (2.43%)
$47
12 days ago
(12-Oct-2026)
12/26 (46.15%)
$1.36 (3.52%)
29
Hold Since 11-Sep-2026
$40
$0.95 (2.43%)
$40
1 months 13 days ago
(11-Sep-2026)
4/4 (100%)
$-3.07 (-7.13%)
32
Buy Since 20-Nov-2025
$62
4 months 7 days ago
(17-Jun-2026)
1/2 (50%)
$15.28 (32.71%)
210
Hold Since 03-Jun-2026
$47
$7.95 (20.36%)
$41
4 months 21 days ago
(03-Jun-2026)
3/6 (50%)
$5.53 (13.33%)
41
Buy Since 07-Jun-2022
8 months ago
(24-Feb-2026)
10/10 (100%)
$32.06 (35.10%)
255
Which stock is Michael Nedelcovych most bullish on?
What Year was the first public recommendation made by Michael Nedelcovych?